MOUNTAIN VIEW PHARMACEUTICALS has a total of 135 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States, EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BAYHILL THERAPEUTICS INC, MOUNTAIN VIEW PHARMACEUTICALS INC and KOURION THERAPEUTICS GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | EPO (European Patent Office) | 12 | |
#3 | China | 9 | |
#4 | Canada | 8 | |
#5 | Hong Kong | 8 | |
#6 | Poland | 7 | |
#7 | WIPO (World Intellectual Property Organization) | 7 | |
#8 | Taiwan | 6 | |
#9 | Japan | 5 | |
#10 | Republic of Korea | 5 | |
#11 | South Africa | 5 | |
#12 | Australia | 4 | |
#13 | Brazil | 4 | |
#14 | Israel | 4 | |
#15 | Mexico | 4 | |
#16 | New Zealand | 4 | |
#17 | Argentina | 3 | |
#18 | Costa Rica | 3 | |
#19 | EAPO (Eurasian Patent Organization) | 3 | |
#20 | Georgia | 3 | |
#21 | Iceland | 3 | |
#22 | Serbia | 3 | |
#23 | Ukraine | 3 | |
#24 | Hungary | 2 | |
#25 | Norway | 2 | |
#26 | Czechia | 1 | |
#27 | Ecuador | 1 | |
#28 | Croatia | 1 | |
#29 | Luxembourg | 1 | |
#30 | Morocco | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Macromolecular chemistry and polymers | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Special macromolecular compounds | |
#7 | Enzymes | |
#8 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Saifer Mark G P | 113 |
#2 | Sherman Merry R | 108 |
#3 | Williams L David | 85 |
#4 | Martinez Alexa L | 42 |
#5 | Kelly Susan J | 42 |
#6 | Hershfield Michael S | 40 |
#7 | Williams David L | 25 |
#8 | Bhaskaran Shyam S | 24 |
#9 | Saifer Mark | 5 |
#10 | Sherman Merry | 5 |
Publication | Filing date | Title |
---|---|---|
ZA200502707B | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | |
NZ541124A | Polymer conjugates of interferon-beta with enhanced biological potency | |
EA013535B1 | Polymer conjugate of bioactive component (variants), method for producing and use thereof, pharmaceutical products on the base thereof | |
CN1852732A | Polymer conjugates of interferon-beta with enhanced biological potency | |
UA86002C2 | POLYMER CONJUGATES WITH DECREASED ANTIGENICITY, METHODS OF PREPARATION AND USES THEREOF <tab> | |
US2004062748A1 | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof | |
WO03002716A2 | Polymer stabilized proteinases | |
US6783965B1 | Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates | |
US6316185B1 | Quantitation of viruses by light scattering | |
CN1322141A | PEG-urate oxidase conjugates and use thereof | |
AU5251599A | Peg-urate oxidase conjugates and use thereof |